-
Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
12 Sep 2024 05:00 GMT
… discuss the 2024 half-year financial results and comment on ongoing corporate … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain …
-
Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update
07 Sep 2023 05:00 GMT
… – Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the … USA 117:24285-24293 About Santhera
Santhera Pharmaceuticals (SIX: SANN) … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain …
-
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
28 Feb 2024 23:03 GMT
… (Nasdaq: CPRX) today reported financial results for the fourth quarter and … and Full Year 2023 Financial Results Total revenues: Total revenues … milestone payment made to Santhera upon the approval of … ET to discuss the financial results and provide a business …
-
Santhera Announces Half-Year 2022 Financial Results and Provides Corporate Update
31 Oct 2022 06:00 GMT
… discuss the 2022 half-year financial results and comment on ongoing corporate … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain …
-
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
09 Aug 2023 20:17 GMT
… Nasdaq: CPRX) today reported financial results for the second quarter of … Duchenne muscular dystrophy, from Santhera Pharmaceuticals, with a PDUFA … in key areas.
Financial Results for Second Quarter 2023 … ET to discuss the financial results and provide a …
-
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
25 Apr 2024 05:00 GMT
… of 2026. PRELIMINARY UNAUDITED 2023 FINANCIAL RESULTS & FINANCING
Revenue from contracts … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain …
-
Full Year Trading Update
04 Mar 2025 06:00 GMT
… Financial Results – April 29, 2025
Annual General Assembly – May 20, 2025
Santhera … the treatment of DMD. About Santhera
Santhera Pharmaceuticals (SIX: SANN) is … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain …
-
Santhera Announces Preliminary 2022 Half-year Financial Results Ahead of Full Report Publication by End of October
29 Sep 2022 07:25 GMT
… , September 29, 2022 – Santhera Pharmaceuticals SANN publishes preliminary financial results for the half … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain …
-
Santhera Announces Preliminary 2022 Half-year Financial Results Ahead of Full Report Publication by End of October
29 Sep 2022 05:00 GMT
… 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) publishes preliminary financial results for the half … or purchase any securities of Santhera Pharmaceuticals Holding AG. This publication may contain certain …
-
Santhera Announces Preliminary 2021 Financial Results and Increases Issued Share Capital to Create Treasury Shares for Future Financing
11 Mar 2022 08:48 GMT
… H2 2024.
PRELIMINARY UNAUDITED 2021 FINANCIAL RESULTS
Total revenue for the twelve … general meeting of Santhera Pharmaceuticals Holding AG on December 15, 2021.
- Santhera Pharmaceuticals Holding AG is required …
About
© 1995-2025